September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Non-vascular alterations and functional impairment persist after Anti-VEGF therapy in Oxygen Induced Retinopathy (OIR) mouse model
Author Affiliations & Notes
  • Magali Evelin Ridano
    Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, CICIBI-CONICET, Córdoba capital, Córdoba, Argentina
  • Valeria Erika Lorenc
    Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, CICIBI-CONICET, Córdoba capital, Córdoba, Argentina
    Department of Ophthalmology, The Johns Hopkins School of Medicine, Baltimore, Maryland, United States
  • Paula Subirada
    Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, CICIBI-CONICET, Córdoba capital, Córdoba, Argentina
  • Maria Constanza Paz
    Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, CICIBI-CONICET, Córdoba capital, Córdoba, Argentina
  • Diego Omar Croci Russo
    Faculty of Medicine, University of Buenos Aires, IByME-CONICET, Capital Federal, Buenos Aires, Argentina
  • Jose D Luna Pinto
    Private Eye Center Romagosa, VER Foundation, Córdoba capital, Córdoba, Argentina
  • Gabriel Adrián Rabinovich
    Faculty of Medicine, University of Buenos Aires, IByME-CONICET, Capital Federal, Buenos Aires, Argentina
  • Maria Cecilia Sanchez
    Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, CICIBI-CONICET, Córdoba capital, Córdoba, Argentina
  • Footnotes
    Commercial Relationships   Magali Ridano, None; Valeria Lorenc, None; Paula Subirada, None; Maria Constanza Paz, None; Diego Croci Russo, None; Jose Luna Pinto, None; Gabriel Rabinovich, None; Maria Sanchez, None
  • Footnotes
    Support  FONCyT, CONICET and SECyT-UNC Grants / SALES FOUNDATION and IBRO International Travel Grants.
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 3636. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Magali Evelin Ridano, Valeria Erika Lorenc, Paula Subirada, Maria Constanza Paz, Diego Omar Croci Russo, Jose D Luna Pinto, Gabriel Adrián Rabinovich, Maria Cecilia Sanchez; Non-vascular alterations and functional impairment persist after Anti-VEGF therapy in Oxygen Induced Retinopathy (OIR) mouse model. Invest. Ophthalmol. Vis. Sci. 2016;57(12):3636.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Neovascular retinopathies are leading causes of irreversible blindness but the successful treatment remains an unmet medical need. Although Vascular Endothelial Growth Factor (VEGF) inhibitors have been established as the mainstay of current treatment, it is unclear why many patients do not improve after therapy. Animal models such as OIR have been developed in order to study these diseases in which hypoxia induces formation of abnormal neovessels (NV) as well as neuronal cell death causing retinal impairment. We hypothesized that although Anti-VEGF therapy reduces the NV do not improve associated non-vascular alterations in these retinopathies.

Methods : C57BL/6 mice (OIR, N=33) were exposed to 75% O2 from postnatal day 7 (P7) to P12, after which they were brought to room air for additional five (P17) or nine days (P26). Age-matched mice maintained in room air (RA, N=15) were used as control. Some OIR mice were intraocular administered at P12 with 1,25 µg of Anti-VEGF (N=9) or vehicle (N=9). At P12, P17 and P26 mice were sacrificed and protein expression in their retinas was analyzed by Western blots. TUNEL assay and vascular staining with GSA isolectin B4 conjugated to Alexa 488 were performed. Retinal function was analyzed by electroretinogram (ERG). GraphPad Prism program was used for statistical analysis according to the experimental data.

Results : VEGF expression was significantly increased in P17 OIR compared to RA (p<0.05) according to the maximum NV day. Since this animal model produces Müller cell activation and neurodegeneration, Glial Fibrillary Acidic Protein (GFAP) expression was increased in P17 and P26 OIR mice; whereas Glutamine Synthase (GS) showed lower levels respect to RA (p<0.05). OIR mice exhibited more TUNEL positive cells in inner retinal layer and a significant decrease in the amplitude of the B ERG wave compared to RA (p<0.05). Anti-VEGF treatment reduced VEGF levels in P17 OIR at the same level of RA (p<0.05) and improved retinal vascularization. However, this treatment did not restore the changes in GFAP and GS expression (p<0.05), the number of TUNEL positive cells and the ERG alterations.

Conclusions : Results in OIR model are consistent with our hypothesis that Anti-VEGF therapy do not prevent or reverse the associated non-vascular alterations. These findings highlight the need for novel and combined therapies for NV retinopathies.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×